Hansa Biopharma AB (publ) (HNSBF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

PresentationGood morning, everyone. Welcome to the 2026 J.P. Morgan Healthcare Conference. My name is Varun, and it is my absolute pleasure to invite on stage Hansa Biopharma, represented by their CEO, Renee Aguiar-Lucander, and to talk about the company and their vision moving forward. Please put your hands together for Renee.Renee Aguiar-LucanderChief Executive Officer Welcome, everybody. We're going to walk through a presentation that has some forward-looking statements. So I refer you to our filings, in ...